145 related articles for article (PubMed ID: 16995345)
1. Candida glabrata fungemia in a diabetic patient with neurogenic bladder: successful treatment with micafungin.
Haruyama N; Masutani K; Tsuruya K; Sugiwaka S; Toyonaga J; Yao T; Goto K; Tokumoto M; Hirakata H; Iida M
Clin Nephrol; 2006 Sep; 66(3):214-7. PubMed ID: 16995345
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment with micafungin in a case of candidemia associated with pneumonia].
Hanada M; Imaoka H; Oshita Y; Rikimaru T; Aizawa H
Kansenshogaku Zasshi; 2005 Apr; 79(4):284-9. PubMed ID: 15977567
[TBL] [Abstract][Full Text] [Related]
3. [A successful treatment with micafungin of candidemia due to Candida krusei].
Nonoyama M; Kume H; Kumagai K; Souma K; Sunakawa K
Kansenshogaku Zasshi; 2003 Nov; 77(11):982-5. PubMed ID: 14672012
[TBL] [Abstract][Full Text] [Related]
4. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of micafungin for the treatment of candidemia.
Andes D; Safdar N
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):662-4. PubMed ID: 16247615
[No Abstract] [Full Text] [Related]
6. [Successful treatment with micafungin (MCFG) of severe peritonitis due to Candida parapsilosis with chronic renal failure patient on hemodialysis].
Hashimoto H; Moriya R; Kamata K; Higashihara M; Yoshida K; Kume H
Kansenshogaku Zasshi; 2005 Mar; 79(3):195-200. PubMed ID: 15977561
[TBL] [Abstract][Full Text] [Related]
7. A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin.
Furuya K; Ito K; Sugiyama K; Tokuda S; Kanemoto H; Kamei K; Shimada T
BMC Infect Dis; 2023 May; 23(1):329. PubMed ID: 37193982
[TBL] [Abstract][Full Text] [Related]
8. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L; Kontoyiannis D; Raffalli J; Mullane KM; Vazquez J; Anaissie EJ; Lipton J; Jacobs P; van Rensburg JH; Rex JH; Lau W; Facklam D; Buell DN
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):654-61. PubMed ID: 16261306
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
11. Candida glabrata liver abscess and fungemia complicating severe calculus cholecystitis in an immunocompetent nondiabetic host.
Lima R; Shams W; Kalra S; Borthwick T
South Med J; 2010 Mar; 103(3):245-7. PubMed ID: 20134390
[TBL] [Abstract][Full Text] [Related]
12. Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.
Yamada SM; Tomita Y; Yamaguchi T; Matsuki T
J Med Case Rep; 2016 Nov; 10(1):316. PubMed ID: 27821139
[TBL] [Abstract][Full Text] [Related]
13. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
[TBL] [Abstract][Full Text] [Related]
15. [A case of chronic mucocutaneous candidasis cured with micafungin].
Suzuki T; Imamura A
Kansenshogaku Zasshi; 2005 Feb; 79(2):143-8. PubMed ID: 15977552
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of micafungin sodium on fungal infection in critical care].
Tateishi Y; Hirasawa H; Oda S; Nakanishi K; Kitamura S; Aikawa N
Nihon Ishinkin Gakkai Zasshi; 2006; 47(4):293-7. PubMed ID: 17086162
[TBL] [Abstract][Full Text] [Related]
18. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
19. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
Shorr AF; Wu C; Kothari S
J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
[TBL] [Abstract][Full Text] [Related]
20. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
Hakki M; Staab JF; Marr KA
Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
